NIH-funded research R03 grant

Impact of Reduced-Exposure Nicotine Products on Mouth Health for High-Risk Adults

Official title: Impact of Reduced-Exposure Nicotine Product Use on Oral Health Conditions among the High-Risk Population

Funded at Roswell Park Cancer Institute Corp · NIH-11354055 · Data updated 2026-11-12

This project looks at how using reduced-exposure nicotine products might affect oral health in adults at high risk for mouth diseases.

More Oral Health research and trials

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionRoswell Park Cancer Institute Corp
NIH-funded
Lab location1 site (Buffalo, United States)
Project startJuly 8, 2026
Project endJuly 7, 2028
Funding year2026
Award (this year)$347,000
NIH project number1R03DE036072-01
Project IDNIH-11354055 on NIH RePORTER

Who could benefit from this research

Could help

Adults 21+ who are at high risk for oral health conditions and use or have used tobacco products.

Less likely to help

Individuals without tobacco exposure or those not at risk for oral health conditions may see no direct benefit.

What this research studies

This grant explores whether switching to reduced-exposure nicotine products changes oral health outcomes at the population level for adults who are already at high risk. Researchers will use national data to compare oral health conditions among those who use reduced-exposure products, traditional tobacco, or have quit, considering time since quitting. The study builds on existing data about tobacco- and nicotine-product use and aims to clarify potential benefits for oral tissues such as the cheek and buccal mucosa. The results could inform future guidance on safer nicotine options and their role in preventing oral diseases associated with tobacco use.

Why it matters

Potential benefit: If successful, findings could help people understand whether switching to reduced-exposure nicotine products may lower the risk of oral health problems.

How similar studies have gone: Existing evidence links quitting tobacco to better oral health, but population-level effects of reduced-exposure products are less clear and may be novel.

Where this research is happening

  • Roswell Park Cancer Institute Corp
    Buffalo, United States
    Active

Researchers

  • Principal investigator: Kasza, Karin a — Roswell Park Cancer Institute Corp
  • Study coordinator: Kasza, Karin a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.